Aurobindo Pharma gets USFDA nod for generic of Revatio drug

Aurobindo Pharma gets USFDA nod for generic of Revatio drug

The drug is used to treat pulmonary arterial hypertension and improve exercise capacity in adults

FPJ Web DeskUpdated: Thursday, December 29, 2022, 11:16 AM IST
article-image
Image credit: Wikipedia (Representative)

Aurobindo Pharma Ltd has received USFDA (US Food and Drug Administration) approval to market sildenafil citrate oral suspension in a 10 mg per mL strength, according to an update on the drug regulator's website.

The drug is a generic version of Viatris Inc's Revatio oral suspension.

It is used to treat pulmonary arterial hypertension and improve exercise capacity in adults.

RECENT STORIES

IPO: Digital Textile Printer Player True Colors Poised For ₹127.96 Crore Public Issue, Will Be...

IPO: Digital Textile Printer Player True Colors Poised For ₹127.96 Crore Public Issue, Will Be...

India Emerges As A Global Leader In Seafood Exports, Supplying To 132 Countries, Aims To Double...

India Emerges As A Global Leader In Seafood Exports, Supplying To 132 Countries, Aims To Double...

National Consumer Helpline Launched To Address Queries & Complaints Related To GST 2.0 Reforms

National Consumer Helpline Launched To Address Queries & Complaints Related To GST 2.0 Reforms

India Crosses Advanced Design & Manufacturing Milestone With Upcoming 2NM Chip Production

India Crosses Advanced Design & Manufacturing Milestone With Upcoming 2NM Chip Production

'Return To US..': Tech Giants Amazon & Microsoft Urge H-1B Visa Holder Employees To Come Back Amid...

'Return To US..': Tech Giants Amazon & Microsoft Urge H-1B Visa Holder Employees To Come Back Amid...